Top

Published in:

01-07-2017 | Educational Review

Delayed graft function and its management in children

Author: Ryszard Grenda

Published in: Pediatric Nephrology | Issue 7/2017

Abstract

Delayed graft function (DGF) is commonly defined as the requirement for dialysis within the first 7 days following renal transplantation. The major underlying mechanism is related to ischaemia/reperfusion injury, which includes microvascular inflammation and cell death and apoptosis, and to the regeneration processes. Several clinical factors related to donor, recipient and organ procurement/transplantation procedures may increase the risk of DGF, including donor cardiovascular instability, older donor age, donor creatinine concentration, long cold ischaemia time and marked body mass index of both the donor and recipient. Some of these parameters have been used in specific predictive formulas created to assess the risk of DGF. A variety of other pre-, intra- and post-transplant clinical factors may also increase the risk of DGF, such as potential drug nephrotoxicity, surgical problems and/or hyperimmunization of the recipient. DGF may decrease the long-term graft function, but data on this effect are inconsistent, partially due to the many different types of organ donation. Relevant management strategies may be classified into the classic clinical approach, which has the aim of minimizing the individual risk factors of DGF, and specific pharmacologic strategies, which are designed to prevent or treat ischaemia/reperfusion injury. Both strategies are currently being evaluated in clinical trials.

Mallon D, Summers D, Bradley J, Pettigrew G (2013) Defining delayed graft function after renal transplantation: simplest is best. Transplantation 96(10):885–889CrossRefPubMed

Perico N, Cattaneo D, Sayegh M, Remuzzi G (2004) Delayed graft function in renal transplantation. Lancet 364:1814–1827CrossRefPubMed

O’Callaghan J, Knight S, Morgan R, Morris P (2012) Preservation solutions for cold storage of kidney allografts: a systematic review and meta-analysis. Am J Transplant 12:896–906CrossRefPubMed

Van Arendonk K, Boyarsky B, Orandi BJ, James NT, Smith J, Colombani P, Segev D (2014) National trends over 25 years in pediatric kidney transplant outcomes. Pediatrics 133(4):594–560CrossRefPubMedPubMedCentral

Marlais M, Pankhurst L, Hudson A, Sharif K, Marks S (2016) UK National Registry of Kidney Donation After Circulatory Death for Pediatric Recipients. Transplantation. doi:10.1097/TP.0000000000001264

Van Arendonk K, James N, Locke J, Montgomery R, Colombani P, Segev D (2011) Late graft loss among pediatric recipients of DCD kidneys. Clin J Am Soc Nephrol 6(11):2705–2711CrossRefPubMedPubMedCentral

De Vries E, Hoogland P, Wind J, Snoeijs M, van Heurn E (2013) Transplantation of kidneys from paediatric DCD donors: a comparison with DBD donors. Nephrol Dial Transplant 28:22–226CrossRef

Dagher N, Lonze B, Singer A, Simpkins C, Desai N, Montgomery R, Segev D (2011) Outcomes and discard of kidneys from pediatric donors after cardiac death. Transplantation 91(7):765–971PubMed

Eltzschig H, Eckle T (2011) Ischemia and reperfusion - from mechanism to transplantation. Nat Med 17:1391–1401CrossRefPubMed

10.

Salvadori M, Rosso G, Bertoni E (2015) Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment. World J Transplant 5(2):52–67PubMedPubMedCentral

11.

Peng T, Jou M (2011) Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci 1201:183–188CrossRef

12.

Gottlieb R (2011) Cell death pathways in acute ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther 16:233–238CrossRefPubMed

13.

Akhtar M, Sutherland A, Huang H, Ploegh R, Pugh C (2014) The role of hypoxia-inducible factors in organ donation and transplantation: current perspective and future opportunities. Am J Transplant 14:1481–1487CrossRefPubMed

14.

Basile D, Fredrich J, Spahic J, Knipe N, Mang H, Leonard E, Changizi-Ashtiyani S, Bacallao R, Molitoris B (2011) Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. J Physiol Renal Psysiol 300:F721–F733CrossRef

15.

Awad A, Rouse M, Huang L, Vergis A, Reutershan J, Cathro H, Linde J, Okusa M (2009) Compartmalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int 75:689–698CrossRefPubMedPubMedCentral

16.

Fuquay R, Renner B, Kulik L, McCullough J, Amura C, Strassheim D, Pelanda R, Torres R, Thurman J (2013) Renal ischemia-reperfusion injury amplifies the humoral immune response. J Am Soc Nephrol 24:1063–1072CrossRefPubMedPubMedCentral

17.

Solini S, Aiello S, Cassis P, Scudeletti P, Azzolini N, Mister M, Rocchetta F, Abbate M, Pereira R, Noris M (2012) Prolonged ischemia accelerates cellular and humoral chronic rejection in a rat model of kidney transplantation. Transplant Int 25:347–356CrossRef

18.

Chen G, Chen S, Cheb X (2013) Role of the complement and perspectives for intervention in transplantation. Immunobiology 218:827–827

19.

Louvar D, Ki N, Snyder J, Peng Y, Kasiske B, Israni A (2009) “Nature vs Nurture” study of deceased donor pairs in kidney transplantation. J Am Soc Nephrol 20:1351–1358CrossRefPubMedPubMedCentral

20.

Agarval S, Oak N, Siddique J, Harland R, Abbo D (2009) Changes in pediatric renal transplantation after implementation of the revised deceased donor kidney allocation policy. Am J Transplant 9:1237–1242CrossRef

21.

Harambat J, van Stralen KJ, Schaefer F, Grenda R, Jankauskiene A, Kostic M, Macher MA, Maxwell H, Puretic Z, Raes A, Rubik J, Sørensen SS, Toots U, Topaloglu R, Tönshoff B, Verrina E, Jager KJ (2013) Disparities in policies, practices and rates of pediatric kidney transplantation in Europe. Am J Transplant 13(8):2066–2074CrossRefPubMed

22.

Cesca E, Ghirardo G, Kiblawi R, Murer L, Gamba P, Zanon G (2014) Delayed graft function in pediatric deceased donor kidney transplantation: donor-related risk factors and impact on two-year graft function and survival: a single-center analysis. Pediatr Transplant 18(4):357–362CrossRefPubMed

23.

Jeldes C, Cardinal H, Duclos A, Shariat S, Suardi N, Capitanio U, Hébert M, Karakiewicz P (2009) Prediction of delayed graft function after renal transplantation. Can Urol Assoc 3:377–382CrossRef

24.

Irish W, Ilsley J, Schnitzler M, Fenf A, Brennan D (2010) A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 10:2279–2286CrossRefPubMed

25.

Chapal M, LeBorgne F, Legendre C, Kreis H, Mourad G, Garrigue V, Morelon E, Buron F, Rostaing L, Kamar N, Kessler M, Ladrière M, Soulillou JP, Launay K, Daguin P, Offredo L, Giral M, Foucher Y, 6 (2014) A useful scoring system for the prediction and management of delayed graft function following kidney transplantation from cadaveric donors. Kidney Int 86:1130–1139CrossRefPubMed

26.

Parikh C, Jani A, Mishra J, Ma Q, Kelly C, Kelly C, Barasch J, Edelstein CL, Devarajan P (2006) Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 6:1639–1645CrossRefPubMed

27.

Peräsaari JP, Kyllönen LE, Salmela KT, Merenmies JM (2016) Pre-transplant donor-specific anti-human leukocyte antigen antibodies are associated with high risk of delayed graft function after renal transplantation. Nephrol Dial Transplant 31(4):672–678CrossRefPubMed

28.

Redfield RR, Scalea JR, Zens TJ, Muth B, Kaufman DB, Djamali A, Astor BC, Mohamed M (2016) Predictors and outcomes of delayed graft function after living-donor kidney transplantation. Transpl Int 29(1):81–87CrossRefPubMed

29.

Rodrigo E, Lopez-Rasines G, Ruiz J, Lastra P, Gomez-Dermitt V, Gómez-Alamillo C, González-Cotorruelo J, Calabia A, Arias M (2010) Determinants of resistive index shortly after transplantation: independent relationship with delayed graft function. Nephron Clin Prat 114(3):C178–C186CrossRef

30.

Kikić Z, Lorenz M, Sunder-Plassmann G, Schillinger M, Regele H, Györi G, Mühlbacher F, Winkelmayer WC, Böhmig GA (2009) Effect of hemodialysis before transplant surgery on renal allograft function -a pair of randomized controlled trials. Transplantation 88(12):1377–1385CrossRefPubMed

31.

Van Loo A, Vanholder R, Bernaert P, Vermassen F, Van der Vennet M, Lameire N (1998) Pretransplantation hemodialysis strategy influences early renal graft function. J Am Soc Nephrol 9(3):473–481PubMed

32.

Woo Y, Craig A, King B, Junor B, McMillan M, Briggs J, Rodger R (2002) Biocompatible membranes do not promote graft recovery following cadaveric renal transplantation. Clin Nephrol 57:38–44CrossRefPubMed

33.

Issa N, Kukla A (2014) Peritoneal dialysis immediately after renal transplantation. Adv Perit Dial 30:83–86PubMed

34.

Kotloff RM, Blosser S, Fulda GJ, Malinoski D, Ahya VN, Angel L, Byrnes MC, DeVita MA, Grissom TE, Halpern SD, Nakagawa TA, Stock PG, Sudan DL, Wood KE, Anillo SJ, Bleck TP, Eidbo EE, Fowler RA, Glazier AK, Gries C, Hasz R, Herr D, Khan A, Landsberg D, Lebovitz DJ, Levine DJ, Mathur M, Naik P, Niemann CU, Nunley DR, O’Connor KJ, Pelletier SJ, Rahman O, Ranjan D, Salim A, Sawyer RG, Shafer T, Sonneti D, Spiro P, Valapour M, Vikraman-Sushama D, Whelan TP, Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Donor Management Task Force (2015) Management of the potential organ donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med 43(6):1291–1325

35.

Cavaillé-Coll M, Bala S, Velidedeoglu E, Hernandez A, Archdeacon P, Gonzalez G, Neuland C, Meyer J, Albrecht R (2013) Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation. Am J Transplant 13:1134–1148CrossRefPubMed

36.

Lachance S, Barry J (1985) Effect of furosemide on dialysis requirement following cadaveric kidney transplantation. J Urol 133(6):950–951PubMed

37.

Wever K, Menting T, Rovers M, van der Vliet J, Rongen G, Masereeuw R, Ritskes-Hoitinga M, Hooijmans CR, Warlé M (2012) Ischemic preconditioning in the animal kidney: a systemic review and meta-analysis. PLoS One 7:e32296CrossRefPubMedPubMedCentral

38.

van der Akker E, Maninveld O, Hesselink D, de Bruin R, Ijzermans J, Dor F (2013) Protection against renal Ischemia-Reperfusion-Injury by ischemic postconditioning. Transplantation 95(11):1299–1305CrossRefPubMed

39.

Schnuelle P, Gottmann U, Hoeger S, Boesebeck D, Lauchart W, Weiss C, Fischereder M, Jauch K, Heemann U, Zeier M, Hugo C, Pisarski P, Krämer BK, Lopau K, Rahmel A, Benck U, Birck R, Yard BA (2009) Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 302(10):1067–1075CrossRefPubMed

40.

Cicora F, Roberti J, Lausada N, Gonzalez P, Guerrieri D, Stringa P, Cicora P, Vásquez D, González I, Palti G, Intile D, Raimondi C (2012) Donor preconditioning with rabbit anti-rat thymocyte immunoglobulin ameliorates ischemia reperfusion injury in rat kidney transplantation. Transplant Immunol 27:1–7CrossRef

41.

Hu M, Shi M, Zhang J, Quinones H, Kuro-o M, Moe O (2010) Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int 78:1240–1251CrossRefPubMedPubMedCentral

42.

Kelpke S, Chen B, Bradley K, Teng X, Chumley P, Kelpke S, Chen B, Bradley K, Teng X (2012) Sodium nitrite protects against kidney injury induced by brain death and improves post-transplant function. Kidney Int 82:304–313CrossRefPubMedPubMedCentral

43.

Parsons R, Guarrera J (2014) Preservation solutions for static cold storage of abdominal grafts; which is the best? Curr Opin Organ Transplant 19:100–107CrossRefPubMed

44.

Moers C, Smits J, Maathuis M, Treckmann J, van Gelder F, Napieralski B, van Kasterop-Kutz M, van der Heide J, Squifflet J, van Heurn E, Kirste G, Rahmel A, Leuvenink H, Paul A, Pirenne J, Ploeg R (2009) Machine perfusion or cold storage in deceased donor kidney transplantation. N Eng J Med 360:7–19CrossRef

45.

Gill J, Dong J, Eng M, Landsberg D, Gill J (2014) Pulsative perfusion reduced the risk of delayed graft function in deceased donor kidney transplants, irrespective of donor type and cold ischemic time. Transplantation 97(6):668–674PubMed

46.

Metzger R, Delmonico F, Feng S, Port F, Wynn J, Merion R (2003) Expanded criteria donors for kidney transplantation. Am J Transplant 3[Suppl 4]:114–125

47.

Danilovic A, Lucon A, Srougi M, Shimizu M, Ianhez NW, Seguro A (2011) Protective effect of N-acetylocysteine on early outcomes of deceased kidney transplantation. Transplant Proc 43(5):1443–1449

48.

Imamura R, Moriyama T, Isaka Y, Namba Y, Ichimaru N, Ichimaru N, Takahara S, Okuyama A (2007) Erythropoeitin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor 1-alpha. Transplantation 83:1371–1379CrossRefPubMed

49.

Sureshkumar K, Hussian S, Ko T, Thai N, Marcus R (2012) Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial. Clin Am J Soc Nephrol 7(9):1498–1506CrossRef

50.

Eculizumab for prevention and treatment of IRI (2016). URL:http://clinicaltrial.gov/

51.

Castellano G, Melchiorre R, Loverre A, Ditonno O, Montinaro V, Rossini M, Divella C, Battaglia M, Lucarelli G, Annunziata G, Palazzo S, Selvaggi FP, Staffieri F, Crovace A, Daha MR, Mannesse M, van Wetering S, Paolo Schena F, Grandaliano G (2010) Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-repefusion-induced renal damage. Am J Pathol 176:1648–1659CrossRefPubMedPubMedCentral

52.

MRC Centre for Transplantation. An investigation into treatment to the donor kidney to see if it improves the recovery of the kidney after transplantation (2016). URL: http://www.isrctn.com/ISRTCTN49958194

53.

Snoeijs MG, Wiermans B, Christiaans MH, van Hooff JP, Timmerman BE, Schurink GW, Buurman WA, van Heurn LW (2007) Recipient hemodynamics during non-heart-beating donor kidney transplantation are major predictors of primary nonfunction. Am J Transplant 7(5):1158–1566CrossRefPubMed

54.

Diekmann F, Campistol JM, Saval N, Gutiérrez-Dalmau A, Arellano EM, Crespo M, Rossich E, Esforzado N, Cofán F, Ricart MJ, Torregrosa JV, Oppenheimer F (2007) Sequential quadruple immunosuppression including sirolimus in extended criteria and nonheartbeating donor kidney transplantation. Transplantation 84(3):429–432CrossRefPubMed

55.

Shaffer D, Langone A, Nylander WA, Goral S, Kizilisik AT, Helderman JH (2003) A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function. Clin Transplant 17(S9):31–34CrossRefPubMed

56.

Knight RJ, Kerman RH, Schoenberg L, Podder H, Van Buren CT, Katz S, Kahan BD (2004) The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function. Transplantation 78(6):904–910CrossRefPubMed

57.

McTaggart RA, Gottlieb D, Brooks J, Bacchetti P, Roberts JP, Tomlanovich S, Feng S (2003) Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 3(4):416–423CrossRefPubMed

58.

Liu Y, Zhou P, Han M, Xue CB, Hu XP, Li C (2010) Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis. Transplant Proc 42(5):1667–1670CrossRefPubMed

59.

Noël C, Abramowicz D, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squifflet JP, Bayle F, Wissing KM, Hazzan M (2009) Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol 20(6):1385–1392CrossRefPubMedPubMedCentral

60.

Kamar N, Garrigue V, Karras A, Mourad G, Lefrançois N, Charpentier B, Legendre C, Rostaing L (2006) Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: a randomized, multicenter study. Am J Transplant 6:1042–1048CrossRefPubMed

61.

Chapal M, Foucher Y, Marguerite M, Neau K, Papuchon E, Daguin P, Morélon E, Mourad G, Cassuto E, Ladrière M, Legendre C, Giral M (2015) PREventing Delayed Graft Function by Driving Immunosuppressive InduCtion Treatment (PREDICT-DGF): study protocol for a randomized controlled trial. Trials 16:282 (1–6)CrossRefPubMedPubMedCentral

62.

Singh R, Farney A, Rogers J, Zuckerman J, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta RJ (2011) Kidney transplantation from donation after cardiac death; lack of impact of delayed graft function on post-transplant outcomes. Clin Transplant 25(2):255–264CrossRefPubMed

63.

Kayler L, Srinivas T, Schold J (2011) Influence of CIT-induced DGF on kidney transplant outcomes. Am J Transplant 11:2657–2664CrossRefPubMed

64.

Butala N, Reese P, Doshi M, Parikh C (2013) Is delayed graft function causally associated with long-term outcomes after kidney transplantation? Instrumental variable analysis. Transplantation 95(8):1008–1014CrossRefPubMedPubMedCentral

65.

Nagaraja P, Roberts G, Stephens M, Horvath S, Fialova J, Chavez R, Asderakis A, Kaposztas Z (2012) Influence of delayed graft function and acute rejection on outcomes after kidney transplantation from donors after cardiac death. Transplantation 94(12):1218–1223CrossRefPubMed

66.

Yarlagadda S, Coca S, Formica R, Poggio ED, Parikh CR (2009) Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 24(3):1039–1047CrossRefPubMed

67.

Quiroga I, McChane P, Koo D, Gray D, Friend P, Fuggle S, Darby C (2006) Mahor effects of delayed graft function and cold ischemia time on renal graft survival. Nephrol Dial Transplant 21:1689–1696CrossRefPubMed

Title: Delayed graft function and its management in children
Author: Ryszard Grenda
Publication date: 01-07-2017
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 7/2017
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-016-3528-9

At a glance: The STEP trials

Springer Medicine

Delayed graft function and its management in children

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2017

Challenges in establishing genotype–phenotype correlations in ARPKD: case report on a toddler with two severe PKHD1 mutations

Erratum to: mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy

Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients

Potassium: friend or foe?

Oral paricalcitol: expanding therapeutic options for pediatric chronic kidney disease patients

Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome